Gil Bianco

BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.

Part of The Tel Aviv Stock Exchange Ltd., The Tel Aviv Stock Exchange (Investment Management) is a company that provides fund management services. The company is based in Tel Aviv, Israel. Ittai Ben Zeev has been the CEO of the Israeli company since 2017.

Fischer Pharmaceutical Laboratories (1975) Ltd. is a multinational group of companies that is a leader in Israel in the development of protective and therapeutic skin and eye products. Fischer Pharmaceutical Laboratories (1975 is based in Israel. The Israeli company's products include Pink Roll On Anti-Perspirant, a spray oil for high and broad protection against sun radiation, and Emol Baby Oil, which provides immediate relief and moisturizes dry, red, and irritated skin. The private company's products are based on therapeutic oils, plant extracts, and vitamins that provide moisture for 24 hours.

Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel.

ClearCut Medical Ltd. develops proprietary technology and tools for removal of cancer. Its product ClearSightTM MRI System, focuses on breast cancer lumpectomy for intraoperative margin assessment of surgically removed lumps. The firms applications include breast cancer biopsies, margin assessment of skin cancer, prostate cancer, colorectal cancer and lung cancer tissue microstructure. The company was founded by Eyal Kolka and Erez Golan in 2010 and is headquartered in Rehovot, Israel.

Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel.

Clear-Cut Ltd. engages in the design and manufacture of command and control systems, and in the provision of aerospace consultation. It operates through the following divisions: C2 Consulting, C3 Cyber, and C4 Command and Control Systems. The C2 Consulting division is active in the Aerospace, Command and Control Systems, and Defense and Security sectors. The C3 Cyber division provides organizations with cyber security products such as mobile defense and Information Technology Network Security. The C4 Command and Control Systems division specializes in the development and integration of command and control systems for a variety of needs and requirements. The company was founded by Omri Yoffe in 2008 and is headquartered in Petah Tikva, Israel.